Biobanks play a pivotal role in the field of biomedical research. A wide range of biospecimens including plasma, saliva, blood, and purified DNA are maintained by biobanks. These biospecimens are compiled to study the unique and general features of the continuous cell line and determine the presence or absence of contaminants. Biobanks usually compile the specimens on the basis of various genetic and other traits such as ethnicity, gender, age, and blood type.

1. Human Biobanking Ownership Market -
Global Industry Analysis, Size, Share, Growth,
Trends, and Forecast 2016 - 2024
Transparency Market Research Reports incorporated a definite business
overview and investigation inclines on "Human Biobanking Ownership
Market". This report likewise incorporates more illumination about
fundamental review of the business including definitions, requisitions
and worldwide business sector industry structure.
Biobanks play a pivotal role in the field of biomedical research. A wide
range of biospecimens including plasma, saliva, blood, and purified
DNA are maintained by biobanks. These biospecimens are compiled to
study the unique and general features of the continuous cell line and
determine the presence or absence of contaminants.
Biobanks usually compile the specimens on the basis of various genetic
and other traits such as ethnicity, gender, age, and blood type. To
understand the impact of environmental factors on the human genes,
some of the samples are also collected depending upon whether the
donor has been exposed to radiation and other substances.
The human biobanking ownership market can be segmented into private
banks, public banks, hospitals, biotechnology and pharmaceutical
companies, diagnostics, transplantation, and biobank storage companies,
and medical institutions, research, and forensics. The private and public
banks can be further classified into disease-based banks, population-
based banks, and academics.

2. The genetic data compiled by human biobanks helps scientists to
understand hereditary diseases and the interaction of environmental and
genetic factors. Studying the correlation between environmental and
genetic factors is crucial to understand the mutations caused in the
genes. Furthermore, these biobanks offer researchers an extensive pool
of samples on the basis of age, gender, education, and lifestyle. All these
factors have contributed toward the growth of the global human
biobanking ownership market.
Cost is one of the primary factors inhibiting the growth of the global
human biobanking ownership market. The process of sequencing
genome is both tedious and expensive. As a result, government-owned
biobanks usually outsource this process to research organizations.
Compared to sequencing of genomes, genotyping is cheaper and about
10 times faster than harvesting the entire genetic code. Furthermore,
concerns regarding the security of the genetic data across human
biobanks have also hampered the growth of the market. In the U.S.,
23andMe, a California-based personal genomics and biotechnology
company has been accused of selling the genetic data of over one
million customers for profit.
In the near future, the global human biobanking ownership market is
expected to be governed by laws to protect the privacy of gene donors
and establish their rights. For example, in Estonia, the Human Genes
Research Act passed in 1999 provides donors full authority over who
can access their data and establishes anonymity in clinical research.
Such laws will help in the growth of the global human biobanking
ownership market.
Browse Full Research Report on Human Biobanking Ownership
Market: http://www.transparencymarketresearch.com/human-
biobanking-ownership-market.html

3. The global human biobanking ownership market can be segmented into
four key regions: Europe, Asia Pacific, North America, and Rest of the
World. Among these, Asia Pacific has been driving the global market
growth owing to the rapid growth of the private biobanks and clinical
research organizations in the region. Demand witnessed in North
America and Europe is also significantly aiding the growth of the
market.
In Europe, countries such as Estonia are focusing on collecting the DNA
of every citizen in order to enrich their national biobank. In Estonia, the
national biobank program started in 2000 by collecting DNA samples
from a quarter of the country’s population. While these DNA samples
are mostly used for clinical research, the government is planning to use
this data to build a robust health care infrastructure by offering
personalized care. The Government of Estonia has already started
developing a system to make this genetic data available to citizens and
doctors.
Some of the key players in the global human biobanking ownership
market are Affymetrix Inc., Abbott Laboratories, Acorda Therapeutics,
Alpha Cord Inc., Autogen Inc., Biobank Ireland Trust, BioCision,
Biokryo GmbH, BioLife Solutions Inc., Biomatrica Inc., BioStorage
Technologies Inc., Cells4Life Ltd., Cesca Therapeutics Inc., China Cord
Blood Corporation, Core Dynamics Inc., and Cryo Bio System.
The report offers a comprehensive evaluation of the market. It does so
via in-depth qualitative insights, historical data, and verifiable
projections about market size. The projections featured in the report
have been derived using proven research methodologies and
assumptions. By doing so, the research report serves as a repository of
analysis and information for every facet of the market, including but not
limited to: Regional markets, technology, types, and applications.

4. About Us
Transparency Market Research (TMR) is a global market intelligence
company providing business information reports and services. The
company’s exclusive blend of quantitative forecasting and trend analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants use
proprietary data sources and various tools and techniques to gather and
analyze information.
TMR’s data repository is continuously updated and revised by a team of
research experts so that it always reflects the latest trends and
information. With extensive research and analysis capabilities,
Transparency Market Research employs rigorous primary and secondary
research techniques to develop distinctive data sets and research material
for business reports.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com